2.4.0.8119 - Disclosure - Discontinued Operations of Adeona Clinical Laboratory and Note Receivable (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$P04_01_2013To06_30_2013http://www.sec.gov/CIK0000894158duration2013-04-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$P04_01_2012To06_30_2012http://www.sec.gov/CIK0000894158duration2012-04-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$P01_01_2013To06_30_2013http://www.sec.gov/CIK0000894158duration2013-01-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$P01_01_2012To06_30_2012http://www.sec.gov/CIK0000894158duration2012-01-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 4us-gaap_OperatingExpensesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Operating Costs and Expenses:2false 5us-gaap_GeneralAndAdministrativeExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse12580001258USD$falsetruefalse2truefalsefalse11760001176USD$falsetruefalse3truefalsefalse23800002380USD$falsetruefalse4truefalsefalse26440002644USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2General and administrative3true 4syn_DiscontinuedOperationIncomeLossOfDiscontinuedOperationsAbstractsyn_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Other Income:4false 5us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntityus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse-156000-156USD$falsefalsefalse3truefalsefalse00USD$falsefalsefalse4truefalsefalse493000493USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of income (loss) from a disposal group, net of income tax, reported as a separate component of income before extraordinary items after deduction or consideration of the amount allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 true2Income (loss) from discontinued operations5false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false USDtruefalse$P04_01_2013To06_30_2013_AdeonaClinicalLaboratoryMemberusgaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxishttp://www.sec.gov/CIK0000894158duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseAdeona Clinical Laboratory [Member]us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxisxbrldihttp://xbrl.org/2006/xbrldisyn_AdeonaClinicalLaboratoryMemberus-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Adeona Clinical Laboratory [Member]6false 4syn_LaboratoryFeesNetsyn_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse00USD$falsefalsefalse3truefalsefalse00USD$falsefalsefalse4truefalsefalse115000115USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of expense provided in the period for laboratory costs incurred on or before the balance sheet date.No definition available.false2Laboratory fees, net7true 4us-gaap_OperatingExpensesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Operating Costs and Expenses:8false 5us-gaap_GeneralAndAdministrativeExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse156000156USD$falsefalsefalse3truefalsefalse00USD$falsefalsefalse4truefalsefalse183000183USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2General and administrative9false 5syn_DisposalGroupIncludingDiscontinuedOperationLaboratoryServicesCostssyn_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse00USD$falsefalsefalse3truefalsefalse00USD$falsefalsefalse4truefalsefalse116000116USD$falsefalsefalsexbrli:monetaryItemTypemonetaryTotal costs related to laboratory services rendered by an entity during the reporting period.No definition available.false2Cost of laboratory services10false 5us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse156000156USD$falsefalsefalse3truefalsefalse00USD$falsefalsefalse4truefalsefalse299000299USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of operating expenses attributable to the disposal group, including a component of the entity (discontinued operation), during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 true2Total operating costs and expenses11false 4us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse-156000-156USD$falsefalsefalse3truefalsefalse00USD$falsefalsefalse4truefalsefalse-184000-184USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of operating income or loss attributable to the disposal group, including a component of the entity (discontinued operation), during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 true2Loss from discontinued operations12true 4syn_DiscontinuedOperationIncomeLossOfDiscontinuedOperationsAbstractsyn_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Other Income:13false 5us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse00USD$falsefalsefalse3truefalsefalse00USD$falsefalsefalse4truefalsefalse677000677USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of gain (loss), after tax expense or benefit and not previously recognized, resulting from the sale of a business component.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 false2Gain on sale of Adeona Clinical Laboratory14false 5us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntityus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse00USD$falsetruefalse2truefalsefalse-156000-156USD$falsetruefalse3truefalsefalse00USD$falsetruefalse4truefalsefalse493000493USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of income (loss) from a disposal group, net of income tax, reported as a separate component of income before extraordinary items after deduction or consideration of the amount allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 true2Income (loss) from discontinued operationsfalseDiscontinued Operations of Adeona Clinical Laboratory and Note Receivable (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.syntheticbiologics.com/role/DiscontinuedOperationsOfAdeonaClinicalLaboratoryAndNoteReceivableDetails414